To summarize the role and mechanisms of ETV4 in cancer biology, particularly in colorectal cancer (CRC), and to explore its biomarkers and therapeutic potential.
Approach:
Overview of ETV4: ETV4 is a member of the ETS transcription factor family, recognized for its oncogenic functions in various cancers, particularly in CRC, where it is involved in tumor cell proliferation, invasion, and other malignant behaviors.
Key Findings:
ETV4 is frequently overexpressed in CRC and associated with poor prognosis, particularly in advanced disease stages.
Activation of ETV4 by oncogenic pathways such as MAPK, PI3K/Akt, and WNT leads to tumor progression and metastasis.
ETV4 may serve as a promising biomarker for CRC diagnosis and prognosis, particularly in the context of adenoma-to-adenocarcinoma progression.
Interpretation:
ETV4 plays a significant role in the oncogenesis of CRC, influencing various tumor characteristics and potentially serving as a therapeutic target.
Limitations:
The mechanisms of ETV4 in immune evasion and tumor microenvironment remodeling are not fully understood, and current research lacks systematic summaries on ETV4's specific roles in CRC.
Conclusion:
ETV4 is a critical factor in CRC biology, though further research is needed to fully elucidate its mechanisms.
